Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts

E-ISSN： 1096-8652|90|7|E139-E141

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.7, 2015-07, pp. : E139-E141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2375-2382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic utility of six mutated genes for older patients with acute myeloid leukemia

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1664-1670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia

Acta Haematologica, Vol. 137, Iss. 4, 2017-04 ,pp. : 195-200

Karger

Access to resources Recommend Favorite

Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2840-2848

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite